AG˹ٷ

STOCK TITAN

Kraig Biocraft Laboratories Sets New Production Record and Advances Spider Silk Reeling with Successful Implementation of Automated Reeling Equipment

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Kraig Biocraft Laboratories (OTCQB: KBLB) has achieved a significant production milestone in spider silk manufacturing with the successful implementation of automated reeling equipment. The company processed over 250 kilograms of spider silk cocoons in a single run, setting a new record.

The automated system allows for precise control of reeling speeds and temperatures, optimizing fiber consistency and output. This advancement replaces conventional multi-end systems, improving throughput and labor efficiency. The achievement supports Kraig Labs' strategy of building a vertically integrated production model for spider silk at scale, complementing their recent expansion of rearing capacity in Asia and development of new spider silk strains.

Kraig Biocraft Laboratories (OTCQB: KBLB) ha raggiunto un importante traguardo nella produzione di seta di ragno grazie all'implementazione con successo di attrezzature automatizzate per l'avvolgimento. L'azienda ha processato oltre 250 chilogrammi di bozzoli di seta di ragno in un'unica sessione, stabilendo un nuovo record.

Il sistema automatizzato consente un controllo preciso delle velocità di avvolgimento e delle temperature, ottimizzando la consistenza e la resa delle fibre. Questo progresso sostituisce i tradizionali sistemi multi-end, migliorando la produttività e l'efficienza del lavoro. Questo risultato supporta la strategia di Kraig Labs di costruire un modello di produzione verticalmente integrato per la seta di ragno su larga scala, integrando la recente espansione della capacità di allevamento in Asia e lo sviluppo di nuovi ceppi di seta di ragno.

Kraig Biocraft Laboratories (OTCQB: KBLB) ha alcanzado un hito importante en la producción de seda de araña con la implementación exitosa de equipos automatizados de devanado. La empresa procesó más de 250 kilogramos de capullos de seda de araña en una sola corrida, estableciendo un nuevo récord.

El sistema automatizado permite un control preciso de las velocidades y temperaturas de devanado, optimizando la consistencia y el rendimiento de las fibras. Este avance reemplaza los sistemas convencionales multi-extremo, mejorando la productividad y la eficiencia laboral. Este logro respalda la estrategia de Kraig Labs de construir un modelo de producción verticalmente integrado para la seda de araña a gran escala, complementando su reciente expansión de capacidad de cría en Asia y el desarrollo de nuevas cepas de seda de araña.

Kraig Biocraft Laboratories (OTCQB: KBLB)� 자동 감기 장비� 성공적인 도입으로 거미� 제조에서 중요� 생산 이정표를 달성했습니다. 회사� � 번의 작업에서 250킬로그램 이상� 거미� 고치� 처리하며 새로� 기록� 세웠습니�.

자동� 시스템은 감기 속도와 온도� 정밀하게 제어하여 섬유� 일관성과 생산량을 최적화합니다. � 발전은 기존� 다중 엔드 시스템을 대체하� 처리량과 노동 효율성을 향상시킵니다. � 성과� 아시아에서의 사육 능력 확장� 새로� 거미� 품종 개발� 함께, 대규모 거미� 생산� 위한 수직 통합 생산 모델 구축이라� Kraig Labs� 전략� 지원합니다.

Kraig Biocraft Laboratories (OTCQB : KBLB) a atteint une étape importante dans la production de soie d'araignée grâce à la mise en place réussie d'équipements automatisés d'enroulement. La société a traité plus de 250 kilogrammes de cocons de soie d'araignée en une seule opération, établissant un nouveau record.

Le système automatisé permet un contrôle précis des vitesses et des températures d'enroulement, optimisant la consistance et le rendement des fibres. Cette avancée remplace les systèmes multi-brins conventionnels, améliorant le débit et l'efficacité du travail. Cette réussite soutient la stratégie de Kraig Labs visant à construire un modèle de production intégré verticalement pour la soie d'araignée à grande échelle, complétant leur récente expansion de la capacité d'élevage en Asie et le développement de nouvelles souches de soie d'araignée.

Kraig Biocraft Laboratories (OTCQB: KBLB) hat einen bedeutenden Produktionsmeilenstein in der Herstellung von Spinnenseide erreicht, indem automatisierte Abwickelgeräte erfolgreich eingesetzt wurden. Das Unternehmen verarbeitete in einem einzigen Durchlauf über 250 Kilogramm Spinnenseidenkokons und stellte damit einen neuen Rekord auf.

Das automatisierte System ermöglicht eine präzise Steuerung der Abwickelgeschwindigkeiten und Temperaturen, wodurch die Faserkonsistenz und der Output optimiert werden. Dieser Fortschritt ersetzt herkömmliche Mehrfachsysteme und verbessert Durchsatz und Arbeitseffizienz. Dieser Erfolg unterstützt die Strategie von Kraig Labs, ein vertikal integriertes Produktionsmodell für Spinnenseide im großen Maßstab aufzubauen und ergänzt die jüngste Erweiterung der Aufzuchtkapazitäten in Asien sowie die Entwicklung neuer Spinnenseidenstämme.

Positive
  • Set new production record of over 250 kilograms of spider silk cocoons in a single run
  • Successfully implemented automated reeling equipment, improving throughput and labor efficiency
  • Enhanced fiber quality and consistency through automated process control
  • Demonstrated compatibility of proprietary spider silk cocoons with advanced production systems
Negative
  • None.

Improved processing unlocks greater quality and efficiency for recombinant spider silk fiber

ANN ARBOR, Mich., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced the recent successful production of reeled raw recombinant spider silk using automated equipment. This batch set a new single run record, processing more than 250 kilograms of spider silk cocoons and represents a major step forward in improving the quality, yield, and scalability of spider silk production.

Automated Reeling of Kraig Labs Recombinant Spider Silk

The use of automated reeling equipment allows Kraig Labs to fine-tune and adapt the reeling process specifically for the unique properties of spider silk, compared to traditional silkworm silk. By modifying machine settings, reeling speeds, and temperatures, the team is optimizing fiber consistency and maximizing silk output. These improvements are critical in translating the natural strength and elasticity of spider silk into finished materials for commercial applications.

“This successful automated reeling run demonstrates our ability to enhance fiber quality, adapting existing production capacity for spider silk manufacturing,� said Jon Rice, COO of Kraig Labs. “Our team is making continuous refinements to tailor the reeling equipment for spider silk, and we’re already seeing how those adjustments lead to better, more consistent fibers.�

Automated reeling replaces conventional multi-end systems, significantly improving throughput, labor efficiency, and downstream silk quality. The compatibility of Kraig Labs� proprietary spider silk cocoons with these advanced systems is central to the Company’s effort to build a vertically integrated production model for spider silk at scale.

This achievement builds upon recent operational momentum, including the expansion of rearing capacity in Asia and the development of new spider silk strains. Together, these advances support the Company’s broader mission to bring high-performance, eco-friendly spider silk fibers to market.

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit .

For details about other recent Kraig Labs advancements, please watch the Company's investor conference at or on the Company's YouTube Channel .

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to

* For a description of our historical leadership in this technology, please follow this link

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.
(720) 288-8495

A photo accompanying this announcement is available at


FAQ

What production record did Kraig Biocraft Laboratories (KBLB) achieve in August 2025?

Kraig Biocraft Laboratories processed over 250 kilograms of spider silk cocoons in a single run using automated reeling equipment, setting a new production record.

How does the new automated reeling equipment benefit KBLB's spider silk production?

The automated equipment improves fiber quality, throughput, and labor efficiency by allowing precise control of reeling speeds and temperatures, replacing conventional multi-end systems.

What are the key advantages of KBLB's automated spider silk reeling process?

The automated process enables better fiber consistency, maximized silk output, and improved quality control through fine-tuned machine settings, reeling speeds, and temperatures.

How does this advancement fit into Kraig Biocraft Laboratories' overall strategy?

This advancement supports KBLB's strategy to build a vertically integrated production model for spider silk at scale, complementing their expansion of rearing capacity in Asia and development of new spider silk strains.

What commercial applications is KBLB targeting with their spider silk production?

KBLB is focusing on translating the natural strength and elasticity of spider silk into finished materials for commercial applications, though specific end-uses are not detailed in the announcement.
Kraig Biocraft Laboratories In

OTC:KBLB

KBLB Rankings

KBLB Latest News

KBLB Stock Data

83.80M
784.01M
25.16%
0.01%
Specialty Chemicals
Basic Materials
United States
Ann Arbor